USE OF THE COMBINATION OF THE HCV-1 E2 PROTEIN (484-499) AND THE HUMAN PANCREATIC POLYPEPTIDE AS A THERAPEUTIC AGENT

摘要

The present invention is directed to the use of the combination of the peptide compounds Pro-Tyr-Cys-Trp-His-Tyr-Pro-Pro-Lys-Pro-Cys-Gly-lle-Val-Pro-Ala-OH and Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln- Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-lle-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease.